UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
1 clinical trials · Sponsor
◉ Watch UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC (NCT07725796) | UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. | 2026-09-30 |
Track UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.